DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection | MicrobiomeTrials← Back to trialsNCT02772003
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2016-06-06Est. Completion: 2020-03-04
Enrollment target: 33 participants Locations- Mayo Clinic in Florida, Jacksonville, Florida, United States
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
- Case Western Reserve University, Cleveland, Ohio, United States
- Temple University Hospital, Philadelphia, Pennsylvania, United States
- University of Puerto Rico, San Juan, Puerto Rico
Other microbiome trials you might be interested in
CKDLow Protein Dietary IntakeMalnutrition (Calorie)
Purpose of study To evaluate suitability of two flavours of a high energy low protein formula (Renalive® LP) as oral nut…
Kaohsiung City, TaiwanCompleted Apr 21, 2026
Chronic Hepatitis BMetabolic Associated Fatty Liver Disease
This is a retrospective cross-sectional observational clinical study. We will collect clinical medical records of patien…
Foshan, ChinaCompleted Oct 31, 2025